Vidita Choudhry - Concepedia

Author

Vidita Choudhry

Science Applications International Corporation (United States)

Also Known As

V Choudhry, V. Choudhry, Vidita Choudhry

Publications

1.5K

Citations

H-Index

Concepts

All Affiliations

Science Applications International Corporation (United States)Uniformed Services University of the Health Sciences National Cancer Institute National Institutes of Health Frederick National Laboratory for Cancer Research

About

Vidita Choudhry is an author at Science Applications International Corporation (United States) specializing in medicine, virology, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	9	9	1K
2	Immunology	7	7	876
3	Microbiology	3	3	642
4	Biomolecular Engineering	2	2	248
5	Cell Biology	1	1	12

Vidita Choudhry

Publications

1.4K

Citations

H-Index

Page 1

	Year	Citations
Ephrin-B2 ligand is a functional receptor for Hendra virus and Nipah virus Matthew Bonaparte, Antony S. Dimitrov, Katharine N. Bossart, Proceedings of the National Academy of Sciences Membrane FusionMolecular VirologyVirus InfectionNipah VirusPathogenesis	2005	469
Structure of Severe Acute Respiratory Syndrome Coronavirus Receptor-binding Domain Complexed with Neutralizing Antibody Ponraj Prabakaran, Jianhua Gan, Yang Feng, Journal of Biological Chemistry	2006	263
Potent Neutralization of Hendra and Nipah Viruses by Human Monoclonal Antibodies Zhongyu Zhu, Antony S. Dimitrov, Katharine N. Bossart, Journal of Virology VaccinationMolecular VirologyNipah VirusesPotent NeutralizationNipah Virus	2005	168
Neutralization assays for differential henipavirus serology using Bio-Plex Protein Array Systems Katharine N. Bossart, Jennifer A. McEachern, Andrew C. Hickey, Journal of Virological Methods Differential Henipavirus SerologyPathogen DetectionPathogenesisBioanalysisSerologic Testing	2007	138
Novel human monoclonal antibodies to insulin-like growth factor (IGF)-II that potently inhibit the IGF receptor type I signal transduction function Yang Feng, Zhongyu Zhu, Xiaodong Xiao, Molecular Cancer Therapeutics	2006	93
Identification and Characterization of a New Cross-Reactive Human Immunodeficiency Virus Type 1-Neutralizing Human Monoclonal Antibody Xiaodong Xiao, Igor A. Sidorov, Vidita Choudhry, Journal of Virology Human RetrovirusVirus EntryImmunologyAntiviral ResponseAntiviral Therapy	2004	80
Increased efficacy of HIV-1 neutralization by antibodies at low CCR5 surface concentration Vidita Choudhry, Mei-Yun Zhang, Ilia Harris, Biochemical and Biophysical Research Communications Human RetrovirusHiv-1 NeutralizationImmunologyAntiviral TherapyAntiviral Response	2006	59
Cross-reactive HIV-1 neutralizing monoclonal antibodies selected by screening of an immune human phage library against an envelope glycoprotein (gp140) isolated from a patient (R2) with broadly HIV-1 neutralizing antibodies Vidita Choudhry, Mei-Yun Zhang, Igor A. Sidorov, Virology Human RetrovirusHiv-1 Neutralizing AntibodiesImmunologyAntiviral TherapyAntiviral Response	2007	58
Detection of Mycobacterium tuberculosis Antigens in Urinary Proteins of Tuberculosis Patients Vidita Choudhry, Richa Saxena European Journal of Clinical Microbiology & Infectious Diseases Pulmonary TuberculosisUrologyTuberculosis PreventionTuberculosis PatientsTuberculosis	2001	35
Impact of antibody framework residue VH-71 on the stability of a humanised anti-MUC1 scFv and derived immunoenzyme Juergen Krauss, Michaela A.E. Arndt, Zhongyu Zhu, British Journal of Cancer	2004	30

Page 1